Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Scheibe

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Harm Reduction Journal|August 25, 2020
Harm reduction in an emergency response to homelessness during South Africa's COVID-19 lockdownTessa S Marcus, Jan Heese, Andrew Scheibe, et al.
The International Journal on Drug Policy|January 24, 2025
Feasibility of implementing viral hepatitis services into a correctional service facility in Cape Town, South AfricaAndrew Scheibe, Joel Steingo, Gaynor Grace, et al.
The Lancet. HIV|December 4, 2024
HIV incidence and factors associated with HIV risk among people who inject drugs engaged with harm-reduction programmes in four provinces in South Africa: a retrospective cohort studyAdelina Artenie, Rachel Perry, Memory Mahaso, et al.
African Journal of Reproductive Health|June 9, 2015
The promise and peril of pre-exposure prophylaxis (PrEP): using social science to inform prep interventions among female sex workersJennifer L Syvertsen, Angela M Robertson Bazzi, Andrew Scheibe, et al.
Harm Reduction Journal|June 9, 2017
Using a programmatic mapping approach to plan for HIV prevention and harm reduction interventions for people who inject drugs in three South African citiesAndrew Scheibe, Shaun Shelly, Andrew Lambert, et al.
BMC Infectious Diseases|September 7, 2020
Hepatitis B, hepatitis C and HIV prevalence and related sexual and substance use risk practices among key populations who access HIV prevention, treatment and related services in South Africa: findings from a seven-city cross-sectional survey (2017)Andrew Scheibe, Katherine Young, Anna Versfeld, et al.
The International Journal on Drug Policy|November 10, 2024
Drug use patterns and health problems among people who use drugs in Guinea-Bissau (2022): A cross-sectional survey using respondent-driven samplingAndrew Scheibe, Andreia Teixeira, Mamadu Aliu Djaló, et al.
Plos One|January 15, 2016
Human Rights Violations among Men Who Have Sex with Men in Southern Africa: Comparisons between Legal ContextsRyan Zahn, Ashley Grosso, Andrew Scheibe, et al.
The Lancet. Global Health|December 12, 2025
Addressing policy barriers to scaling up needle and syringe programmes: a global call to actionGuillaume Fontaine, Emma Day, Niklas Luhmann, et al.
Plos One|December 1, 2025
Factors associated with phylogenetic clustering of hepatitis C virus, mainly among people who inject drugs who access HIV prevention services in South Africa, 2016-2017Nkosenhle L Ndlovu, Andrew Scheibe, Harry Hausler, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Harm Reduction Journal|August 25, 2020
Harm reduction in an emergency response to homelessness during South Africa's COVID-19 lockdownTessa S Marcus, Jan Heese, Andrew Scheibe, et al.
The International Journal on Drug Policy|January 24, 2025
Feasibility of implementing viral hepatitis services into a correctional service facility in Cape Town, South AfricaAndrew Scheibe, Joel Steingo, Gaynor Grace, et al.
The Lancet. HIV|December 4, 2024
HIV incidence and factors associated with HIV risk among people who inject drugs engaged with harm-reduction programmes in four provinces in South Africa: a retrospective cohort studyAdelina Artenie, Rachel Perry, Memory Mahaso, et al.
African Journal of Reproductive Health|June 9, 2015
The promise and peril of pre-exposure prophylaxis (PrEP): using social science to inform prep interventions among female sex workersJennifer L Syvertsen, Angela M Robertson Bazzi, Andrew Scheibe, et al.
Harm Reduction Journal|June 9, 2017
Using a programmatic mapping approach to plan for HIV prevention and harm reduction interventions for people who inject drugs in three South African citiesAndrew Scheibe, Shaun Shelly, Andrew Lambert, et al.
BMC Infectious Diseases|September 7, 2020
Hepatitis B, hepatitis C and HIV prevalence and related sexual and substance use risk practices among key populations who access HIV prevention, treatment and related services in South Africa: findings from a seven-city cross-sectional survey (2017)Andrew Scheibe, Katherine Young, Anna Versfeld, et al.
The International Journal on Drug Policy|November 10, 2024
Drug use patterns and health problems among people who use drugs in Guinea-Bissau (2022): A cross-sectional survey using respondent-driven samplingAndrew Scheibe, Andreia Teixeira, Mamadu Aliu Djaló, et al.
Plos One|January 15, 2016
Human Rights Violations among Men Who Have Sex with Men in Southern Africa: Comparisons between Legal ContextsRyan Zahn, Ashley Grosso, Andrew Scheibe, et al.
The Lancet. Global Health|December 12, 2025
Addressing policy barriers to scaling up needle and syringe programmes: a global call to actionGuillaume Fontaine, Emma Day, Niklas Luhmann, et al.
Plos One|December 1, 2025
Factors associated with phylogenetic clustering of hepatitis C virus, mainly among people who inject drugs who access HIV prevention services in South Africa, 2016-2017Nkosenhle L Ndlovu, Andrew Scheibe, Harry Hausler, et al.
Pageof 5